Global Kinetics Corporation and Parkinson’s Foundation Announce First Patient Enrolled in APPRISE Clinical Study for Optimization of Parkinson’s Treatment
10x Genomics’ pharmaceutical and cell therapy customers can leverage Immunai’s artificial intelligence and machine learning technologies to generate granular…